People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Please provide your email address to receive an email when new articles are posted on . Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma.

Findings showed that in patients treated with glecaprevir/pibrentasvir, the overall SVR12 rate was 96%, with 0 patients experiencing virologic failure. The Food and ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

Present interferon-based therapy for chronic hepatitis C is limited by both efficacy and tolerability. Telaprevir and boceprevir are the first two direct-acting antiviral drugs (DAAs) that inhibit ...

In the wake of recent breakthroughs in the management of hepatitis C virus (HCV) infection, with several new promising medications available on the market and more being studied in clinical trials, it ...

AbbVie (NYSE: ABBV) announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and ...

The clearance rates for those coinfected with HIV and hepatitis C virus (HCV) are still higher than those with HCV alone. Direct-acting antivirals (DAAs) are a means of curing HCV with an efficacy of ...

Atea Pharmaceuticals, Inc. Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026 ...

The Centers for Disease Control (CDC) recommends screening for exposure with HCV antibody (anti-HCV) and follow-up with HCV-RNA testing. About 70% to 86% of patients with positive results of anti-HCV ...